Literature DB >> 24972095

Indole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysis.

Lan Chen1, Pei-Hsin Cheng2, Xiao-Mei Rao3, Kelly M McMasters4, Heshan Sam Zhou5.   

Abstract

Epidemiological studies suggest that high intake of cruciferous vegetables is associated with a lower risk of cancer. Experiments have shown that indole-3-carbinol (I3C), a naturally occurring compound derived from cruciferous vegetables, exhibits potent anticarcinogenic properties in a wide range of cancers. In this study, we showed that higher doses of I3C (≥400 μM) induced apoptotic cancer cell death and lower doses of I3C (≤200 μM) repressed cancer cell growth concurrently with suppressed expression of cyclin E and its partner CDK2. Notably, we found that pretreatment with low doses of I3C enhanced Ad-mediated oncolysis and cytotoxicity of human carcinoma cells by synergistic upregulation of apoptosis. Thus, the vegetable compound I3C as a dietary supplement may benefit cancer prevention and improve Ad oncolytic therapies.

Entities:  

Keywords:  I3C; adenovirus; cancer; cancer prevention; cyclin E; oncolysis; virotherapy

Mesh:

Substances:

Year:  2014        PMID: 24972095      PMCID: PMC4128868          DOI: 10.4161/cbt.29690

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  45 in total

1.  Cyclin E ablation in the mouse.

Authors:  Yan Geng; Qunyan Yu; Ewa Sicinska; Manjusri Das; Jürgen E Schneider; Shoumo Bhattacharya; William M Rideout; Roderick T Bronson; Humphrey Gardner; Piotr Sicinski
Journal:  Cell       Date:  2003-08-22       Impact factor: 41.582

Review 2.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

3.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

4.  A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet.

Authors:  M Ishiyama; H Tominaga; M Shiga; K Sasamoto; Y Ohkura; K Ueno
Journal:  Biol Pharm Bull       Date:  1996-11       Impact factor: 2.233

5.  E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.

Authors:  Xiao-Mei Rao; Michael T Tseng; Xinyu Zheng; Yanbin Dong; Azemat Jamshidi-Parsian; Timothy C Thompson; Malcolm K Brenner; Kelly M McMasters; Heshan Sam Zhou
Journal:  Cancer Gene Ther       Date:  2004-09       Impact factor: 5.987

Review 6.  Cancer-specific viruses and the development of ONYX-015.

Authors:  Frank McCormick
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

7.  Cyclin-dependent regulation of G1 in mammalian fibroblasts.

Authors:  M Ohtsubo; J M Roberts
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

8.  Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice.

Authors:  M A Morse; S D LaGreca; S G Amin; F L Chung
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

9.  CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.

Authors:  T Fernandes-Alnemri; G Litwack; E S Alnemri
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

10.  Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.

Authors:  M Ohtsubo; A M Theodoras; J Schumacher; J M Roberts; M Pagano
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

View more
  3 in total

1.  Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.

Authors:  Justine M Grixti; Steve O'Hagan; Philip J Day; Douglas B Kell
Journal:  Front Pharmacol       Date:  2017-03-27       Impact factor: 5.810

2.  Dose-Dependent Responses of I3C and DIM on T-Cell Activation in the Human T Lymphocyte Jurkat Cell Line.

Authors:  Man Liu; Rumana Yasmeen; Naomi K Fukagawa; Liangli Yu; Young S Kim; Thomas T Y Wang
Journal:  Int J Mol Sci       Date:  2017-07-01       Impact factor: 5.923

3.  Current results on the biological and pharmacological activities of Indole-3-carbinol.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2018-02-06       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.